サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1490983

静脈内水分補給療法の世界市場規模調査：サービス別、コンポーネント別、エンドユーザー別、地域別予測：2022～2032年

Global Intravenous hydration therapy Market Size study, by Service, by Component, by End User and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
静脈内水分補給療法の世界市場規模調査：サービス別、コンポーネント別、エンドユーザー別、地域別予測：2022～2032年
出版日: 2024年06月02日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈内（IV）水分補給療法の世界市場は、2023年に約25億1,000万米ドルと評価され、予測期間2024～2032年には8.21%以上の健全な成長率で成長すると予測されています。

静脈内水分補給療法の世界市場は、脱水を治療し必須栄養素を供給するために、血流に直接水分を投与することを含みます。いくつかの重要な動向が市場の大幅な成長につながっています。糖尿病やがんなどの慢性疾患の有病率の上昇により、特に病院での静脈内水分補給療法の需要が増加しています。ウェルネスや予防医療の人気の高まりは、外来クリニックや移動式点滴療法サービスの増加につながり、市場拡大の原動力となっています。さらに、世界の高齢化により、経口での水分摂取が困難な高齢患者の間で静脈内水分補給療法の需要が高まっています。スマートポンプや統合モニタリングシステムなどの技術の進歩は、静脈内治療の安全性と効率を高め、市場の成長をさらに後押ししています。こうした動向が、世界の静脈内水分補給療法市場への注目と投資を促進しています。

静脈内水分補給療法の世界市場は、多様な要因によって牽引されています。慢性疾患の世界の蔓延は、臨床現場、特に複雑な病態を持つ患者に対する静脈内治療の需要を高めています。また、スポーツ医療やウェルネスセグメントでの静脈内水分補給療法の採用拡大も市場の成長を後押ししています。点滴機器の技術的進歩は安全性と有効性を高め、市場拡大にさらに拍車をかけています。しかし、こうした市場促進要因の一方で、市場には一定の抑制要因も存在します。主要阻害要因の1つは、感染、体液過多、静脈刺激など、静脈内治療に伴う潜在的リスクです。これらのリスクは、安全で効果的な治療を確実にするために、厳格なプロトコルと熟練した医療専門家を必要とします。静脈内水分補給療法の利点とこれら固有のリスクとのバランスをとることは、医療プロバイダーや業界利害関係者にとって依然として重要な課題であり、市場力学や採用率に影響を与えています。

静脈内水分補給療法の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、その他その他です。北米は、確立された医療インフラ、高度な医療技術、さまざまな病状に対する静脈内治療の高い採用率により、圧倒的な地域となっています。同地域の強固な償還政策と主要市場参入企業の存在感が、静脈内水分補給療法市場における主導的地位をさらに高めています。同地域は、総合的なウェルネスに対する患者の支出と可処分所得の高さを誇り、これが同市場の採用を増加させています。さらに、同地域の主要利害関係者は、進化する消費者ニーズに対応するため、市場における最新技術の導入に一貫して注意を払っており、これが市場拡大を後押しする要因となっています。一方、アジア太平洋の市場は、予測期間中に最も速い速度で発展すると予想されます。

本レポートに含まれる主要市場参入企業は以下の通りです。

  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B.Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare Ltd.
  • Baxter International Inc.
  • Drip Hydration
  • Smiths Medical, Inc.

目次

第1章 世界の静脈内水分補給療法市場の定義と調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 除外項目
    • 制限事項
    • 供給サイドの分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブ概要

  • 静脈内水分補給療法の世界市場規模・予測、2022～2032年
  • 地域別概要
  • セグメント別概要
    • サービス別
    • コンポーネント別
    • エンドユーザー別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 静脈内水分補給療法の世界市場力学

  • 市場促進要因
  • 市場課題
  • 市場機会

第4章 静注水和療法の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 静脈内水分補給療法の世界市場規模・予測：サービス別、2022～2032年

  • 免疫ブースター
  • エネルギーブースター
  • スキンケア
  • 偏頭痛
  • その他

第6章 静脈内水分補給療法の世界市場規模・予測：コンポーネント別、2022～2032年

  • 薬用
  • 非薬用

第7章 静脈内水分補給療法の世界市場規模・予測：エンドユーザー別、2022～2032年

  • 病院・クリニック
  • ウェルネスセンター・スパ
  • 在宅医療
  • その他

第8章 静脈内水分補給療法の世界市場規模・予測：地域別、2022～2032年

  • 北米の静脈内水分補給療法市場
    • 米国
      • サービスの内訳：市場規模と予測、2022～2032年
      • コンポーネントの内訳：市場規模・予測、2022～2032年
      • エンドユーザーの内訳：市場規模予測、2022～2032年
    • カナダの静脈内水分補給療法市場
  • 欧州の静脈内水分補給療法市場
    • 英国の静脈内水分補給療法市場
    • ドイツの静脈内水分補給療法市場
    • フランスの静脈内水分補給療法市場
    • スペインの静脈内水分補給療法市場
    • イタリアの静脈内水分補給療法市場
    • その他の欧州の静脈内水分補給療法市場
  • アジア太平洋の静脈内水分補給療法市場
    • 中国の静脈内水分補給療法市場
    • インドの静脈内水分補給療法市場
    • 日本の静脈内水分補給療法市場
    • オーストラリアの静脈内水分補給療法市場
    • 韓国の静脈内水分補給療法市場
    • その他のアジア太平洋の静脈内水分補給療法市場
  • ラテンアメリカの静脈内水分補給療法市場
    • ブラジルの静脈内水分補給療法市場
    • メキシコの静脈内水分補給療法市場
    • その他のラテンアメリカ静脈内水分補給療法市場
  • 中東・アフリカの静脈内水分補給療法市場
    • サウジアラビアの静脈内水分補給療法市場
    • 南アフリカの静脈内水分補給療法市場
    • その他の中東・アフリカの静脈内水分補給療法市場

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Core IV Therapy, LLC
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • Cryojuvenate UK Ltd.
    • B. Braun Medical Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • NexGen Health
    • JW Life Science Corporation
    • Amanta Healthcare
    • Baxter International Inc.
    • Smiths Medical, Inc.
    • Drip Hydration

第10章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1.Global Intravenous (IV) Hydration Therapy market, report scope
  • TABLE 2.Global Intravenous (IV) Hydration Therapy market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3.Global Intravenous (IV) Hydration Therapy market estimates & forecasts by Service 2022-2032 (USD Billion)
  • TABLE 4.Global Intravenous (IV) Hydration Therapy market estimates & forecasts by Component 2022-2032 (USD Billion)
  • TABLE 5.Global Intravenous (IV) Hydration Therapy market estimates & forecasts by End User 2022-2032 (USD Billion)
  • TABLE 6.Global Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7.Global Intravenous (IV) Hydration Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8.Global Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9.Global Intravenous (IV) Hydration Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10.Global Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11.Global Intravenous (IV) Hydration Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12.Global Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13.Global Intravenous (IV) Hydration Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14.Global Intravenous (IV) Hydration Therapy market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15.Global Intravenous (IV) Hydration Therapy market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16.U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 17.U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18.U.S. Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 19.Canada Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 20.Canada Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21.Canada Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 22.UK Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 23.UK Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24.UK Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 25.Germany Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 26.Germany Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27.Germany Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 28.France Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 29.France Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30.France Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 31.Italy Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 32.Italy Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33.Italy Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 34.Spain Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 35.Spain Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36.Spain Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 37.RoE Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 38.RoE Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39.RoE Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 40.China Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 41.China Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42.China Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 43.India Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 44.India Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45.India Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 46.Japan Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 47.Japan Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48.Japan Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 49.Australia Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 50.Australia Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51.Australia Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 52.South Korea Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 53.South Korea Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.South Korea Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 55.
  • TABLE 56.RoAPAC Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 57.RoAPAC Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58.RoAPAC Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 59.Brazil Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 60.Brazil Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61.Brazil Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 62.Mexico Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 63.Mexico Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64.Mexico Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 65.RoLA Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 66.RoLA Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67.RoLA Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 68.Saudi Arabia Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69.Saudi Arabia Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70.Saudi Arabia Intravenous (IV) Hydration Therapy market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 71.South Africa Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 72.
  • TABLE 73.South Africa Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74.South Africa Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75.RoMEA Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76.RoMEA Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77.RoMEA Intravenous (IV) Hydration Therapy market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 78.List of secondary sources, used in the study of Global Intravenous (IV) Hydration Therapy Market.
  • TABLE 79.List of primary sources, used in the study of Global Intravenous (IV) Hydration Therapy Market.
  • TABLE 80.Years considered for the study.
  • TABLE 81.Exchange rates considered.

LIST OF FIGURES

  • FIG 1.Global Intravenous (IV) Hydration Therapy market, research methodology
  • FIG 2.Global Intravenous (IV) Hydration Therapy market, market estimation techniques
  • FIG 3.Global market size estimates & forecast methods.
  • FIG 4.Global Intravenous (IV) Hydration Therapy market, key trends 2023
  • FIG 5.Global Intravenous (IV) Hydration Therapy market, growth prospects 2022-2032
  • FIG 6.Global Intravenous (IV) Hydration Therapy market, porters 5 force model
  • FIG 7.Global Intravenous (IV) Hydration Therapy market, pestel analysis
  • FIG 8.Global Intravenous (IV) Hydration Therapy market, value chain analysis
  • FIG 9.Global Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Billion)
  • FIG 10.Global Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Billion)
  • FIG 11.Global Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Billion)
  • FIG 12.Global Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Billion)
  • FIG 13.Global Intravenous (IV) Hydration Therapy market by segment, 2022 & 2032 (USD Billion)
  • FIG 14.Global Intravenous (IV) Hydration Therapy market, regional snapshot 2022 & 2032
  • FIG 15.North America Intravenous (IV) Hydration Therapy market 2022 & 2032 (USD Billion)
  • FIG 16.Europe Intravenous (IV) Hydration Therapy market 2022 & 2032 (USD Billion)
  • FIG 17.Asia pacific Intravenous (IV) Hydration Therapy market 2022 & 2032 (USD Billion)
  • FIG 18.Latin America Intravenous (IV) Hydration Therapy market 2022 & 2032 (USD Billion)
  • FIG 19.Middle East & Africa Intravenous (IV) Hydration Therapy market 2022 & 2032 (USD Billion)
  • FIG 20.Global Intravenous (IV) Hydration Therapy market, company market share analysis (2023)
目次

Global Intravenous (IV) hydration therapy Market is valued at approximately USD 2.51 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.21% over the forecast period 2024-2032. The Global Intravenous (IV) Hydration Therapy Market involves the administration of fluids directly into the bloodstream to treat dehydration and deliver essential nutrients. Several important trends have led to significant growth in the market. The rising prevalence of chronic diseases such as diabetes and cancer has increased the demand for IV hydration therapy, especially in hospital settings. The growing popularity of wellness and preventive healthcare has led to an increase in outpatient clinics and mobile IV therapy services, driving market expansion. Additionally, the ageing population globally has fueled the demand for IV hydration therapy among elderly patients who have difficulty consuming fluids orally. Advancements in technology, such as smart pumps and integrated monitoring systems, are enhancing the safety and efficiency of IV therapy, further boosting market growth. These trends are driving attention and investment in the Global Intravenous (IV) Hydration Therapy Market.

The Global Intravenous (IV) Hydration Therapy Market is driven by diverse factors. The increasing prevalence of chronic diseases worldwide drives a higher demand for IV therapy in clinical settings, especially for patients with complex conditions. IV hydration therapy's expanding adoption in sports medicine and wellness also boosts market growth. Technological advances in IV equipment enhance safety and efficacy, further fueling market expansion. However, alongside these drivers, the market faces certain restraints. One key restraint is the potential risks associated with IV therapy, including infection, fluid overload, and vein irritation. These risks necessitate stringent protocols and skilled healthcare professionals to ensure safe and effective treatment. Balancing the benefits of IV hydration therapy with these inherent risks remains a critical challenge for healthcare providers and industry stakeholders, influencing market dynamics and adoption rates.

The key regions considered for the Global Intravenous (IV) hydration therapy market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America stands out as a dominating region due to its well-established healthcare infrastructure, advanced medical technologies, and high adoption rates of IV therapy for various medical conditions. The region's robust reimbursement policies and strong presence of key market players further contribute to its leadership position in the IV Hydration Therapy Market. The region boasts high patient spending and high disposable income on overall wellness, which increases the adoption of the market. Furthermore, major stakeholders in the area are consistently placing their attention on implementing modern technologies in the market to accommodate evolving consumer needs, a factor that is expected to boost market expansion. The market in Asia Pacific, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:

  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare Ltd.
  • Baxter International Inc.
  • Drip Hydration
  • Smiths Medical, Inc.

The detailed segments and sub-segment of the market are explained below:

By Service

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Other

By Component

  • Medicated
  • Non-medicated

By End User

  • Hospitals & Clinics
  • Wellness centres and spas
  • Home Healthcare
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Intravenous (IV) Hydration Therapy Market Definition and Research Assumptions

  • 1.1.Research Objective
  • 1.2.Market Definition
  • 1.3.Research Assumptions
    • 1.3.1.Inclusion & Exclusion
    • 1.3.2.Limitations
    • 1.3.3.Supply Side Analysis
      • 1.3.3.1.Availability
      • 1.3.3.2.Infrastructure
      • 1.3.3.3.Regulatory Environment
      • 1.3.3.4.Market Competition
      • 1.3.3.5.Economic Viability (Consumer's Perspective)
    • 1.3.4.Demand Side Analysis
      • 1.3.4.1.Regulatory frameworks
      • 1.3.4.2.Technological Advancements
      • 1.3.4.3.Environmental Considerations
      • 1.3.4.4.Consumer Awareness & Acceptance
  • 1.4.Estimation Methodology
  • 1.5.Years Considered for the Study
  • 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

  • 2.1.Global Intravenous (IV) Hydration Therapy Market Size & Forecast (2022- 2032)
  • 2.2.Regional Summary
  • 2.3.Segmental Summary
    • 2.3.1.By Service
    • 2.3.2.By Component
    • 2.3.3.By End User
  • 2.4.Key Trends
  • 2.5.Recession Impact
  • 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Intravenous (IV) Hydration Therapy Market Dynamics

  • 3.1.Market Drivers
  • 3.2.Market Challenges
  • 3.3.Market Opportunities

Chapter 4.Global Intravenous (IV) Hydration Therapy Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model
    • 4.1.7.Porter's 5 Force Impact Analysis
  • 4.2.PESTEL Analysis
    • 4.2.1.Political
    • 4.2.2.Economical
    • 4.2.3.Social
    • 4.2.4.Technological
    • 4.2.5.Environmental
    • 4.2.6.Legal
  • 4.3.Top investment opportunity
  • 4.4.Top winning strategies
  • 4.5.Disruptive Trends
  • 4.6.Industry Expert Perspective
  • 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by Service 2022-2032

  • 5.1.Immune Boosters
  • 5.2.Energy Boosters
  • 5.3.Skin Care
  • 5.4.Migraine
  • 5.5.Other

Chapter 6.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by Component 2022-2032

  • 6.1. Medicated
  • 6.2.Non-medicated

Chapter 7.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by End User 2022-2032

  • 7.1. Hospitals & Clinics
  • 7.2.Wellness centres and spas
  • 7.3.Home Healthcare
  • 7.4.Others

Chapter 8.Global Intravenous (IV) Hydration Therapy Market Size & Forecasts by Region 2022-2032

  • 8.1.North America Intravenous (IV) Hydration Therapy Market
    • 8.1.1.U.S. Intravenous (IV) Hydration Therapy Market
      • 8.1.1.1. Service breakdown size & forecasts, 2022-2032
      • 8.1.1.2.Component breakdown size & forecasts, 2022-2032
      • 8.1.1.3.End User breakdown size & forecasts, 2022-2032
    • 8.1.2.Canada Intravenous (IV) Hydration Therapy Market
  • 8.2.Europe Intravenous (IV) Hydration Therapy Market
    • 8.2.1.U.K. Intravenous (IV) Hydration Therapy Market
    • 8.2.2.Germany Intravenous (IV) Hydration Therapy Market
    • 8.2.3.France Intravenous (IV) Hydration Therapy Market
    • 8.2.4.Spain Intravenous (IV) Hydration Therapy Market
    • 8.2.5.Italy Intravenous (IV) Hydration Therapy Market
    • 8.2.6.Rest of Europe Intravenous (IV) Hydration Therapy Market
  • 8.3.Asia-Pacific Intravenous (IV) Hydration Therapy Market
    • 8.3.1.China Intravenous (IV) Hydration Therapy Market
    • 8.3.2.India Intravenous (IV) Hydration Therapy Market
    • 8.3.3.Japan Intravenous (IV) Hydration Therapy Market
    • 8.3.4.Australia Intravenous (IV) Hydration Therapy Market
    • 8.3.5.South Korea Intravenous (IV) Hydration Therapy Market
    • 8.3.6.Rest of Asia Pacific Intravenous (IV) Hydration Therapy Market
  • 8.4.Latin America Intravenous (IV) Hydration Therapy Market
    • 8.4.1.Brazil Intravenous (IV) Hydration Therapy Market
    • 8.4.2.Mexico Intravenous (IV) Hydration Therapy Market
    • 8.4.3.Rest of Latin America Intravenous (IV) Hydration Therapy Market
  • 8.5.Middle East & Africa Intravenous (IV) Hydration Therapy Market
    • 8.5.1. Saudi Arabia Intravenous (IV) Hydration Therapy Market
    • 8.5.2. South Africa Intravenous (IV) Hydration Therapy Market
    • 8.5.3.Rest of Middle East & Africa Intravenous (IV) Hydration Therapy Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Core IV Therapy, LLC
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Market Strategies
    • 9.3.2. Cryojuvenate UK Ltd.
    • 9.3.3.B. Braun Medical Inc.
    • 9.3.4.Otsuka Pharmaceutical Co., Ltd.
    • 9.3.5.NexGen Health
    • 9.3.6.JW Life Science Corporation
    • 9.3.7.Amanta Healthcare
    • 9.3.8.Baxter International Inc.
    • 9.3.9. Smiths Medical, Inc.
    • 9.3.10. Drip Hydration

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes